Advanced Biomed Inc. (ADVB) stock
ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
$2.10−0.12 (-5.41%)
Close on Nov 17, 2026Market cap $3.47MP/E 0.4Yield –
Advanced Biomed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Advanced Biomed's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.95M. For fiscal 2026 it was -$1.95M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$1.95M | – |
| FY2025 | Jun 30, 2025 | -$5.83M | – |
| FY2024 | Jun 30, 2024 | -$2.13M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$583.27K | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$239.78K | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$513.56K | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$610.34K | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$1.54M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$3.41M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$841.84K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$29.68K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$475.83K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$1.07M | – |
See a number that looks wrong?